This antagonistic effect observed for SKP2 and p27Kip1 suggests that bortezomib induced- downregulation of SKP2 forms an important mechanism to induce apoptosis in CML cell lines via up-regulation of p27Kip1. This evidence concerns the gene CDKN1B and chronic myelogenous leukemia, BCR-ABL1 positive.